Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Best Therapy for Patients With Neuroendocrine Tumors (BESTTHERAPYNET)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2016 by Zentralklinik Bad Berka
Sponsor:
Information provided by (Responsible Party):
Dieter Hoersch MD, Zentralklinik Bad Berka
ClinicalTrials.gov Identifier:
NCT00815620
First received: December 29, 2008
Last updated: January 4, 2016
Last verified: January 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2016
  Estimated Primary Completion Date: September 2016 (Final data collection date for primary outcome measure)